ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 22348 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 22348; 2) Community: the network communities that were significantly associated with the response to NSC 22348; 3) Molecule: the relationships between components within communities and NSC 22348; 4) MDR: the compounds that were significantly associated with the NSC 22348.

NSC Compound Enrichment Correlation
NSC 694509 Null 0.0217366743178497 0.17516667
NSC 706992 Null 0.0217366743178497 -0.0085973627
NSC 711077 Null 0.0217366743178497 0.29414651
NSC 718781 Erlotinib hydrochloride 0.0217366743178497 -0.36021589
NSC 726217 Combretastatin A4-analogue 0.0217366743178497 0.38092893
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0217366743178497 0.33298876
NSC 743532 Null 0.0217366743178497 0.10313428
NSC 752346 Null 0.0217366743178497 0.1934517
NSC 753661 methyl ester prodigiosene 0.0217366743178497 0.46097169
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0217366743178497 0.27919467
Total:143  Current:77    [First] [Prev] [Next] [Last]